ARENA GROUP

ARENA FURAZOLIDONA FORTE 100MG X 10 COMPRIMATE

You're reading an Auto-translation.

Composition.

One tablet contains furazolidone 100 mg and excipients: microcrystalline cellulose. Polyvidone K 30, croscarmellose sodium, talc, magnesium stearate.

Therapeutic indications.

Enteritis, infectious enterocolitis and food poisoning caused by germs sensitive

to furazolidone, bacillary dysentery, giardiasis.

It can be indicated in trichomoniasis, as well as in the treatment of cholera.

Dosage and administration.

Adults

For the treatment of cholera or other enteric infections: the recommended dose is 100 mg furazolidone, administered orally, 4 times a day, at 6-hour intervals, for 5-7 days.

In the treatment of giardiasis, the recommended dose is 100 mg furazolidone, administered orally, 4 times a day, at 6-hour intervals, for 7-10 days.

Children

For the treatment of cholera or other enteric infections: the recommended dose is 1.25 mg furazolidone/kg, administered orally, 4 times a day, at 6-hour intervals, for 5-7 days.

In case of infestation with Giardia lamblia, the duration of treatment can be extended up to 10 days.

It is recommended to crush and dilute the tablets with a small amount of liquid to obtain a suspension, as the tablets are not suitable for administration to children younger than 6 years.

Precautions.

During treatment and 4 days after its cessation, the consumption of alcoholic beverages (risk of disulfiram-like reactions) and foods containing thiamine (risk of arterial hypertension and other toxic phenomena) is not recommended.

Special warnings.

Pregnancy and breastfeeding

Studies conducted in laboratory animals with doses much higher than those therapeutically recommended for humans, administered for a long time, have not shown fetotoxic effects. Since there are no controlled studies in pregnant women, the administration of furazolidone during pregnancy is not recommended. Administration in the last trimester of pregnancy is contraindicated due to the risk of hemolytic anemia in the fetus.

It is not known whether furazolidone is excreted in breast milk. Therefore, in breastfeeding women, either discontinuation of treatment or discontinuation of breastfeeding should be considered. Administration to women breastfeeding infants younger than 1 month is contraindicated due to the risk of hemolytic anemia in the infant.

Ability to drive vehicles and operate machinery

Furazolidone does not affect the ability to drive vehicles or operate machinery.

Packaging. Box with 2 Al/PVC blisters, each containing 10 tablets.

Page updated on: 09.06.2021